Atossa Therapeutics (ATOS) EBT Margin (2011 - 2015)
Atossa Therapeutics (ATOS) posted quarterly EBT Margin of 147313.65% for Q4 2015, down 2472368.0% year-over-year from N/an in Q4 2014, and down 20.17% quarter-over-quarter from 122589.97% in Q4 2014.
Atossa Therapeutics (ATOS) EBT Margin (2011 - 2015) Analysis & Trends
Atossa Therapeutics (ATOS) has reported EBT Margin for 5 consecutive years, with 147313.65% the latest figure, recorded in Q4 2015.
- In Q4 2015, EBT Margin fell 2472368.0% year-over-year to 147313.65%; the TTM figure through Sep 2016 stood at 366041.41% (up 13138395.0% YoY), while the FY2015 annual figure was 725721.67%, down 69539936.0% from the prior year.
- EBT Margin slipped to 147313.65% in Q4 2015 per ATOS's latest filing, from 122589.97% in the prior quarter.
- Across five years, EBT Margin topped out at 762.0% in Q4 2013 and bottomed at 147313.65% in Q4 2015.
- Historically, EBT Margin has averaged 42949.01% across 5 years, with a median of 23364.27% in 2013.
- Annual changes were most pronounced in 2012 — EBT Margin jumped 7862785 bps — and 2014, when it slumped 12335198 bps.
- Atossa Therapeutics' EBT Margin stood at 80360.2% in 2011, then surged by 98 bps to 1732.35% in 2012, then soared by 144 bps to 762.0% in 2013, then tumbled by 16188 bps to 122589.97% in 2014, then decreased by 20 bps to 147313.65% in 2015.
- Business Quant data shows ATOS's EBT Margin at 147313.65% in Q4 2015, 122589.97% in Q4 2014, and 94728.4% in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.77% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -25.06% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -2.67% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 12.09% |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -147,313.65% |
| Dec 31, 2014 | -122,589.97% |
| Sep 30, 2014 | -94,728.40% |
| Jun 30, 2014 | -32,283.30% |
| Mar 31, 2014 | -9,996.40% |
| Dec 31, 2013 | 762.00% |
| Sep 30, 2013 | -4,851.07% |
| Jun 30, 2013 | -2,144.36% |
| Mar 31, 2013 | -14,445.24% |
| Dec 31, 2012 | -1,732.35% |
| Sep 30, 2012 | -1,082.99% |
| Jun 30, 2012 | -37,374.34% |
| Mar 31, 2012 | -53,145.90% |
| Dec 31, 2011 | -80,360.20% |